|
MechanismD1 receptor antagonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1995 |
100 Clinical Results associated with Yunnan Honghe Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Yunnan Honghe Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Yunnan Honghe Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Yunnan Honghe Pharmaceutical Technology Development Co., Ltd.